Correlation Between Design Therapeutics and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Vir Biotechnology, you can compare the effects of market volatilities on Design Therapeutics and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Vir Biotechnology.
Diversification Opportunities for Design Therapeutics and Vir Biotechnology
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Design and Vir is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Design Therapeutics and Vir Biotechnology
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.17 times more return on investment than Vir Biotechnology. However, Design Therapeutics is 1.17 times more volatile than Vir Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.02 per unit of risk. If you would invest 690.00 in Design Therapeutics on November 2, 2024 and sell it today you would lose (196.00) from holding Design Therapeutics or give up 28.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Design Therapeutics vs. Vir Biotechnology
Performance |
| Timeline |
| Design Therapeutics |
| Vir Biotechnology |
Design Therapeutics and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Vir Biotechnology
The main advantage of trading using opposite Design Therapeutics and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |